Fig. 3From: Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolinTotal pGSN/sEV-pGSN outperforms other markers in predicting chemoresistance. Receiver operating characteristic curve analysis for individual and multi-analyte biomarkers to predict PFI ≤ 12 months. A Total pGSN, sEV-pGSN, and total pGSN/sEV-pGSN. B CA125, total pGSN/CA125, sEV-pGSN/CA125, and (total pGSN/sEV-pGSN)/CA125Back to article page